分泌されるセリン・スレオニンキナーゼは,真核病原体トキソプラズマ・ゴンディの毒性を決定する
1Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63130, USA.
Science (New York, N.Y.)
|December 16, 2006
まとめ
トキソプラズマ・ゴンディの毒性は,ROP18遺伝子によって制御される. 侵入時に分泌されるこのセリン・スレオニンキナーゼは,寄生虫の成長と宿主の死亡率を大幅に増加させ,エフェクター分泌を重要な毒性の要因として強調しています.
科学分野:
- 寄生虫学とは,寄生虫学である.
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- トキソプラズマ・ゴンディ (Toxoplasma gondii) は,高い遺伝的類似性にもかかわらず,異なる菌株間の毒性の有意な変化を示しています.
- T. gondiiの毒性の遺伝的基礎を理解することは,トキソプラズマ症の制御に不可欠です.
研究 の 目的:
- I型トキソプラズマ・ゴンディ菌株の極端な毒性を引き起こす遺伝的要因を特定する.
- 寄生虫の毒性における特定の遺伝子とエフェクタータンパク質の役割を明らかにする.
主な方法:
- 遺伝的マッピングは,寄生虫染色体VIIaの毒性に関連した定量的な特性の位置を特定するために使用されました.
- ポジショナルのクローニングは,候補ウイルス性遺伝子ROP18.を特定するために使用されました.
- ROP18のキナーゼ活性と分泌を評価し,寄生虫の成長と宿主死亡率に対する効果は,トランスフェクション実験を通じて評価された.
主要な成果:
- 染色体VIIaの2つの隣接する定量的な特性の位置は,タイプI系統の毒性に関連していた.
- セリン・スレオニンキナーゼROP18は,主要な毒性遺伝子として特定され,ポリモルフィックであり,宿主細胞に分泌されます.
- 毒性の高いROP18アレルがIII型株に変異すると,寄生虫の成長と宿主死亡率 (4-5ログ) が劇的に増加します.
- ROP18の毒性に関連した属性は,そのキナーゼ活性に依存していた.
結論:
- ROP18はトキソプラズマ・ゴンディの毒性の主要な決定因子である.
- ROP18のようなエフェクタータンパク質の分泌は,寄生虫の毒性を促す重要なメカニズムです.
- ROP18キナーゼの活動は,寄生虫の成長と宿主の死亡率を高める役割に不可欠です.
関連する概念動画
01:36Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...